FBXW7 and pancreatic neoplasm: In our in vitro analysis, we found that knockdown of FBXW7 enhanced cell proliferation, migration, and invasion abilities, and decreased sensitivity to gemcitabine and nab-paclitaxel in pancreatic cancer cells.